SCHEMBL4473883

SCHEMBL4473883

CC(C)c1ccc2c(c1)Cc1cc(C(C)C)ccc1-2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
CYP17A1 P05093 3/20 0.45
HPGD P15428 2/20 0.43
HSD17B10 Q99714 2/20 0.43
GFER P55789 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 2/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 2/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
TRPA1 O75762 1/20 0.40
PTGS1 P23219 1/20 0.40
CACNA1C Q13936 1/20 0.40
PDK2 Q15119 1/20 0.40
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
ALOX12 P18054 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19383233 0.90 CYP17A1 (0.57) LMNACYP17A1HPGDHSD17B10NPSR1
SCHEMBL20085569 0.88 MAPT (0.56) LMNACYP17A1HPGDHSD17B10GFER
SCHEMBL15458064 0.87 HSD17B10 (0.42) LMNACYP17A1HPGDHSD17B10GFER
SCHEMBL20055113 0.86 LMNA (0.52) LMNACYP17A1HPGDHSD17B10GFER
SCHEMBL4898197 0.86 LMNA (0.52) LMNACYP17A1HPGDHSD17B10GFER
SCHEMBL24615546 0.85 LMNA (0.40) LMNACYP17A1HPGDHSD17B10GFER
SCHEMBL15457995 0.85 LMNA (0.40) LMNACYP17A1HPGDHSD17B10GFER
SCHEMBL14675850 0.81 CYP17A1 (0.50) LMNACYP17A1HPGDHSD17B10GFER
SCHEMBL13255926 0.81 LMNA (0.44) LMNACYP17A1HPGDHSD17B10GFER
SCHEMBL24102223 0.80 LMNA (0.47) LMNACYP17A1HPGDHSD17B10GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101107260-B Transition metal complex, method for producing the same, substituted fluorene compound, method for producing the substituted fluorene compound, catalyst component for olefin polymerization, catalyst for olefin polymerization, and method for producing olefin polymer SUMITOMO CHEMICAL CO.,LTD. (JP) 2012-02-08 CN disclosed
US-8084559-B2 Ethylene-vinylcyclohexane copolymers SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-27 US disclosed
EP-2032612-A1 MAGNESIUM CHLOROALKOLATE-BASED CATALYST PRECURSORS Basell Poliolefine Italia S.r.l. (IT) 2009-03-11 EP disclosed
US-20080161514-A1 Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) 2008-07-03 US disclosed
CN-101107260-A Transition metal complex, method for producing the same, substituted fluorene compound, method for producing the substituted fluorene compound, catalyst component for olefin polymerization, catalyst for olefin polymerization, and method for producing olefin polymer SUMITOMO CHEMICAL CO (JP) 2008-01-16 CN disclosed
WO-2007147714-A1 MAGNESIUM CHLOROALKOLATE-BASED CATALYST PRECURSORS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2007-12-27 WO disclosed
CN-1227271-C Solid catalytic composition for olefin polymerization ATOCHEM ELF SA (FR) 2005-11-16 CN disclosed
EP-0889065-B1 Solid catalyst component for the polymerisation of olefins ATOFINA (FR) 2001-08-22 EP disclosed
EP-0666267-B1 Organometallic fluorenyl compounds, preparation, and use PHILLIPS PETROLEUM CO (US) 2001-04-18 EP disclosed
CN-1060176-C Organometallic fluorenyl compounds, preparation, and use PHILLIPS PETROLEUM CO (US) 2001-01-03 CN disclosed
US-6057258-A Solid catalytic component for the polymerization of olefins ELF ATOCHEM S.A. (FR) 2000-05-02 US disclosed
EP-0889065-A1 Solid catalyst component for the polymerisation of olefins ELF ATOCHEM S.A. (FR) 1999-01-07 EP disclosed
CN-1203924-A Solid catalytic composition for olefin polymerization ATOCHEM ELF SA (FR) 1999-01-06 CN disclosed
US-5571880-A CATALYSTS FOR POLYMERIZATION OF OLEFINS ESPECIALLY TO OBTAIN SYNDIOTACTIC POLYMERS PHILLIPS PETROLEUM COMPANY (US) 1996-11-05 US disclosed
CN-1109472-A Organometallic fluorenyl compounds, preparation, and use PHILLIPS PETROLEUM CO (US) 1995-10-04 CN disclosed
EP-0666267-A2 Organometallic fluorenyl compounds, preparation, and use PHILLIPS PETROLEUM COMPANY (US) 1995-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161514-A1 Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer AOC2, ACSL1, ACSL3 LMNA 3520/4885CYP17A1 688/4885HPGD 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.